PDF) WTX101 in patients newly diagnosed with Wilson disease: final

Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis

Diagnosis - Wilson Disease Association

Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease

Wilson Disease - Practical Neurology

PDF) Designing Clinical Trials in Wilson's Disease

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease - Paternostro - 2020 - Liver International - Wiley Online Library

Aftab ALA, Professor, MBBS MD PhD FRCP, University of Surrey, Guildford, School of Biosciences and Medicine & Department of Health Management and Strategy

Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver - The Lancet Gastroenterology & Hepatology

The current Status and New Advances in Diagnosis and Treatment of Wilson Disease – Biomedical and Pharmacology Journal

PDF) Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson's Disease Rating Scale

PDF) Persistence with treatment for Wilson disease: a retrospective study

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease - Paternostro - 2020 - Liver International - Wiley Online Library

PDF) Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment

Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India